Lista de obras -

A pilot study to determine the impact on dyslipidemia of adding tenofovir to stable background antiretroviral therapy: ACTG 5206.

artículo científico publicado en 2010

A9 A method to obtain full-length HIV proviral sequences and their sites of integration

ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia

artículo científico publicado en 2007

Amplifying and quantifying HIV-1 RNA in HIV infected individuals with viral loads below the limit of detection by standard clinical assays

artículo científico publicado en 2011

Analysis of 454 sequencing error rate, error sources, and artifact recombination for detection of Low-frequency drug resistance mutations in HIV-1 DNA.

artículo científico publicado en 2013

Assessing intra-lab precision and inter-lab repeatability of outgrowth assays of HIV-1 latent reservoir size

artículo científico publicado en 2019

Baseline natural killer and T cell populations correlation with virologic outcome after regimen simplification to atazanavir/ritonavir alone (ACTG 5201).

artículo científico publicado en 2014

Blockade of the PD-1 axis alone is not sufficient to activate HIV-1 virion production from CD4+ T cells of individuals on suppressive ART

scientific article published in PLoS ONE

Clonal resistance analyses of HIV type-1 after failure of therapy with didanosine, lamivudine and tenofovir

artículo científico publicado en 2010

Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo

artículo científico publicado en 2016

Combined HIV-1 sequence and integration site analysis informs viral dynamics and allows reconstruction of replicating viral ancestors

artículo científico publicado en 2019

Correction: Performance of Swabs, Lavage, and Diluents to Quantify Biomarkers of Female Genital Tract Soluble Mucosal Mediators.

artículo científico publicado en 2012

Correction: Prevalence of HIV-1 Drug Resistance among Women Screening for HIV Prevention Trials in KwaZulu-Natal, South Africa (MTN-009)

artículo científico publicado en 2014

Correction: The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial.

artículo científico publicado en 2011

Depletion of latent HIV-1 infection in vivo: a proof-of-concept study

artículo científico publicado en 2005

Dynamics of immune reconstitution and activation markers in HIV+ treatment-naïve patients treated with raltegravir, tenofovir disoproxil fumarate and emtricitabine

artículo científico publicado en 2013

E138A in HIV-1 reverse transcriptase is more common in subtype C than B: implications for rilpivirine use in resource-limited settings

artículo científico publicado en 2014

Early Emergence and Long-Term Persistence of HIV-Infected T-Cell Clones in Children

artículo científico publicado en 2021

Factors influencing the emergence and spread of HIV drug resistance arising from rollout of antiretroviral pre-exposure prophylaxis (PrEP)

artículo científico publicado en 2011

Frequent polymorphism at drug resistance sites in HIV-1 protease and reverse transcriptase

artículo científico publicado en 2008

Genetic diversity of simian immunodeficiency virus encoding HIV-1 reverse transcriptase persists in macaques despite antiretroviral therapy

artículo científico publicado en 2010

HIV Infected T Cells Can Proliferate in vivo Without Inducing Expression of the Integrated Provirus

scientific article published on 01 October 2019

HIV-1 continues to replicate and evolve in patients with natural control of HIV infection

artículo científico publicado en 2010

HIV-1 in lymph nodes is maintained by cellular proliferation during antiretroviral therapy

artículo científico publicado en 2019

HIV-1 infection leads to increased transcription of human endogenous retrovirus HERV-K (HML-2) proviruses in vivo but not to increased virion production

artículo científico publicado en 2014

HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study.

artículo científico publicado en 2017

Histone deacetylase inhibitor romidepsin induces HIV expression in CD4 T cells from patients on suppressive antiretroviral therapy at concentrations achieved by clinical dosing

artículo científico publicado en 2014

How Much Do We Know about Drug Resistance Due to PrEP Use? Analysis of Experts' Opinion and Its Influence on the Projected Public Health Impact

artículo científico publicado en 2016

How Much HIV is Alive? The Challenge of Measuring Replication Competent HIV for HIV Cure Research

artículo científico publicado en 2015

In vitro activity of structurally diverse nucleoside analogs against human immunodeficiency virus type 1 with the K65R mutation in reverse transcriptase

artículo científico publicado en 2005

In vitro selection and analysis of human immunodeficiency virus type 1 resistant to derivatives of beta-2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine

artículo científico publicado en 2005

Insertional activation of <i>STAT3</i> and <i>LCK</i> by HIV-1 proviruses in T cell lymphomas

artículo científico publicado en 2021

Lack of detectable HIV-1 molecular evolution during suppressive antiretroviral therapy

artículo científico publicado en 2014

Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation.

artículo científico publicado en 2017

Low frequency nonnucleoside reverse-transcriptase inhibitor-resistant variants contribute to failure of efavirenz-containing regimens in treatment- experienced patients

artículo científico publicado en 2010

Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy

artículo científico publicado en 2008

Lower pre-ART intra-participant HIV-1 pol diversity may not be associated with virologic failure in adults

artículo científico publicado en 2018

Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control

scientific article published on 08 December 2008

Majority of CD4+ T cells from peripheral blood of HIV-1-infected individuals contain only one HIV DNA molecule

artículo científico publicado en 2011

Mechanism for nucleoside analog-mediated abrogation of HIV-1 replication: balance between RNase H activity and nucleotide excision

artículo científico publicado en 2005

Multi-dose Romidepsin Reactivates Replication Competent SIV in Post-antiretroviral Rhesus Macaque Controllers

artículo científico publicado en 2016

Multiple sources of contamination in samples from patients reported to have XMRV infection

artículo científico publicado en 2012

Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis

artículo científico publicado en 2005

Nevirapine- versus lopinavir/ritonavir-based initial therapy for HIV-1 infection among women in Africa: a randomized trial

artículo científico publicado en 2012

New Tools for Quantifying HIV-1 Reservoirs: Plasma RNA Single Copy Assays and Beyond ⬇️

artículo científico publicado el 1 de marzo de 2012

New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma

artículo científico publicado en 2003

No effect of raltegravir intensification on viral replication markers in the blood of HIV-1-infected patients receiving antiretroviral therapy

artículo científico publicado en 2012

No evidence of HIV replication in children on antiretroviral therapy.

artículo científico publicado en 2017

Ongoing HIV Replication During ART Reconsidered

article

Origin of Rebound Plasma HIV Includes Cells with Identical Proviruses That Are Transcriptionally Active before Stopping of Antiretroviral Therapy

artículo científico publicado en 2015

PAPNC, a novel method to calculate nucleotide diversity from large scale next generation sequencing data

artículo científico publicado en 2014

Performance of swabs, lavage, and diluents to quantify biomarkers of female genital tract soluble mucosal mediators

artículo científico publicado en 2011

Persistence of viral reservoirs in multiple tissues after antiretroviral therapy suppression in a macaque RT-SHIV model

artículo científico publicado en 2013

Planning for pre-exposure prophylaxis to prevent HIV transmission: challenges and opportunities

artículo científico publicado en 2010

Potential impact of antiretroviral chemoprophylaxis on HIV-1 transmission in resource-limited settings

artículo científico publicado en 2007

Prevalence of HIV-1 Drug Resistance among Women Screening for HIV Prevention Trials in KwaZulu-Natal, South Africa (MTN-009) ⬇️

artículo científico publicado el 9 de abril de 2013

Proceedings of the Frontiers of Retrovirology Conference 2016.

artículo científico publicado en 2016

Proviruses with identical sequences comprise a large fraction of the replication-competent HIV reservoir

artículo científico publicado en 2017

Quantification of HIV-1 latency reversal in resting CD4+ T cells from patients on suppressive antiretroviral therapy

artículo científico publicado en 2014

RT-SHIV subpopulation dynamics in infected macaques during anti-HIV therapy

artículo científico publicado en 2009

Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy: final 48-week clinical and virologic outcomes

artículo científico publicado en 2009

Single cell analysis of lymph node tissue from HIV-1 infected patients reveals that the majority of CD4+ T-cells contain one HIV-1 DNA molecule

artículo científico publicado en 2013

Single-cell analysis of HIV-1 transcriptional activity reveals expression of proviruses in expanded clones during ART.

artículo científico publicado en 2017

Suppression of viremia and evolution of human immunodeficiency virus type 1 drug resistance in a macaque model for antiretroviral therapy

artículo científico publicado en 2007

The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial

artículo científico publicado en 2010

Therapeutic Vaccination With Dendritic Cells Loaded With Autologous HIV Type 1-Infected Apoptotic Cells

artículo científico publicado en 2015

Towards an HIV cure: a global scientific strategy

artículo científico publicado en 2012

Ultrasensitive allele-specific PCR reveals rare preexisting drug-resistant variants and a large replicating virus population in macaques infected with a simian immunodeficiency virus containing human immunodeficiency virus reverse transcriptase

artículo científico publicado en 2012

Ultrasensitive single-genome sequencing: accurate, targeted, next generation sequencing of HIV-1 RNA.

artículo científico publicado en 2016

Well-mixed plasma and tissue viral populations in RT-SHIV-infected macaques implies a lack of viral replication in the tissues during antiretroviral therapy

artículo científico publicado en 2015

Y chromosome and HIV DNA detection in vaginal swabs as biomarkers of semen and HIV exposure in women

artículo científico publicado en 2014

YKL-40, a marker of simian immunodeficiency virus encephalitis, modulates the biological activity of basic fibroblast growth factor

artículo científico publicado en 2008

Zidovudine (AZT) Monotherapy Selects for the A360V Mutation in the Connection Domain of HIV-1 Reverse Transcriptase ⬇️

artículo científico publicado el 21 de febrero de 2012

Lista de obras de

A pilot study to determine the impact on dyslipidemia of adding tenofovir to stable background antiretroviral therapy: ACTG 5206.

A9 A method to obtain full-length HIV proviral sequences and their sites of integration

ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia

Amplifying and quantifying HIV-1 RNA in HIV infected individuals with viral loads below the limit of detection by standard clinical assays

Analysis of 454 sequencing error rate, error sources, and artifact recombination for detection of Low-frequency drug resistance mutations in HIV-1 DNA.

Assessing intra-lab precision and inter-lab repeatability of outgrowth assays of HIV-1 latent reservoir size

Baseline natural killer and T cell populations correlation with virologic outcome after regimen simplification to atazanavir/ritonavir alone (ACTG 5201).

Blockade of the PD-1 axis alone is not sufficient to activate HIV-1 virion production from CD4+ T cells of individuals on suppressive ART

Clonal resistance analyses of HIV type-1 after failure of therapy with didanosine, lamivudine and tenofovir

Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo

Combined HIV-1 sequence and integration site analysis informs viral dynamics and allows reconstruction of replicating viral ancestors

Correction: Performance of Swabs, Lavage, and Diluents to Quantify Biomarkers of Female Genital Tract Soluble Mucosal Mediators.

Correction: Prevalence of HIV-1 Drug Resistance among Women Screening for HIV Prevention Trials in KwaZulu-Natal, South Africa (MTN-009)

Correction: The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial.

Depletion of latent HIV-1 infection in vivo: a proof-of-concept study

Dynamics of immune reconstitution and activation markers in HIV+ treatment-naïve patients treated with raltegravir, tenofovir disoproxil fumarate and emtricitabine

E138A in HIV-1 reverse transcriptase is more common in subtype C than B: implications for rilpivirine use in resource-limited settings

Early Emergence and Long-Term Persistence of HIV-Infected T-Cell Clones in Children

Factors influencing the emergence and spread of HIV drug resistance arising from rollout of antiretroviral pre-exposure prophylaxis (PrEP)

Frequent polymorphism at drug resistance sites in HIV-1 protease and reverse transcriptase

Genetic diversity of simian immunodeficiency virus encoding HIV-1 reverse transcriptase persists in macaques despite antiretroviral therapy

HIV Infected T Cells Can Proliferate in vivo Without Inducing Expression of the Integrated Provirus

HIV-1 continues to replicate and evolve in patients with natural control of HIV infection

HIV-1 in lymph nodes is maintained by cellular proliferation during antiretroviral therapy

HIV-1 infection leads to increased transcription of human endogenous retrovirus HERV-K (HML-2) proviruses in vivo but not to increased virion production

HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study.

Histone deacetylase inhibitor romidepsin induces HIV expression in CD4 T cells from patients on suppressive antiretroviral therapy at concentrations achieved by clinical dosing

How Much Do We Know about Drug Resistance Due to PrEP Use? Analysis of Experts' Opinion and Its Influence on the Projected Public Health Impact

How Much HIV is Alive? The Challenge of Measuring Replication Competent HIV for HIV Cure Research

In vitro activity of structurally diverse nucleoside analogs against human immunodeficiency virus type 1 with the K65R mutation in reverse transcriptase

In vitro selection and analysis of human immunodeficiency virus type 1 resistant to derivatives of beta-2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine

Insertional activation of <i>STAT3</i> and <i>LCK</i> by HIV-1 proviruses in T cell lymphomas

Lack of detectable HIV-1 molecular evolution during suppressive antiretroviral therapy

Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation.

Low frequency nonnucleoside reverse-transcriptase inhibitor-resistant variants contribute to failure of efavirenz-containing regimens in treatment- experienced patients

Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy

Lower pre-ART intra-participant HIV-1 pol diversity may not be associated with virologic failure in adults

Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control

Majority of CD4+ T cells from peripheral blood of HIV-1-infected individuals contain only one HIV DNA molecule

Mechanism for nucleoside analog-mediated abrogation of HIV-1 replication: balance between RNase H activity and nucleotide excision

Multi-dose Romidepsin Reactivates Replication Competent SIV in Post-antiretroviral Rhesus Macaque Controllers

Multiple sources of contamination in samples from patients reported to have XMRV infection

Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis

Nevirapine- versus lopinavir/ritonavir-based initial therapy for HIV-1 infection among women in Africa: a randomized trial

New Tools for Quantifying HIV-1 Reservoirs: Plasma RNA Single Copy Assays and Beyond ⬇️

New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma

No effect of raltegravir intensification on viral replication markers in the blood of HIV-1-infected patients receiving antiretroviral therapy

No evidence of HIV replication in children on antiretroviral therapy.

Ongoing HIV Replication During ART Reconsidered

Origin of Rebound Plasma HIV Includes Cells with Identical Proviruses That Are Transcriptionally Active before Stopping of Antiretroviral Therapy

PAPNC, a novel method to calculate nucleotide diversity from large scale next generation sequencing data

Performance of swabs, lavage, and diluents to quantify biomarkers of female genital tract soluble mucosal mediators

Persistence of viral reservoirs in multiple tissues after antiretroviral therapy suppression in a macaque RT-SHIV model

Planning for pre-exposure prophylaxis to prevent HIV transmission: challenges and opportunities

Potential impact of antiretroviral chemoprophylaxis on HIV-1 transmission in resource-limited settings

Prevalence of HIV-1 Drug Resistance among Women Screening for HIV Prevention Trials in KwaZulu-Natal, South Africa (MTN-009) ⬇️

Proceedings of the Frontiers of Retrovirology Conference 2016.

Proviruses with identical sequences comprise a large fraction of the replication-competent HIV reservoir

Quantification of HIV-1 latency reversal in resting CD4+ T cells from patients on suppressive antiretroviral therapy

RT-SHIV subpopulation dynamics in infected macaques during anti-HIV therapy

Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy: final 48-week clinical and virologic outcomes

Single cell analysis of lymph node tissue from HIV-1 infected patients reveals that the majority of CD4+ T-cells contain one HIV-1 DNA molecule

Single-cell analysis of HIV-1 transcriptional activity reveals expression of proviruses in expanded clones during ART.

Suppression of viremia and evolution of human immunodeficiency virus type 1 drug resistance in a macaque model for antiretroviral therapy

The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial

Therapeutic Vaccination With Dendritic Cells Loaded With Autologous HIV Type 1-Infected Apoptotic Cells

Towards an HIV cure: a global scientific strategy

Ultrasensitive allele-specific PCR reveals rare preexisting drug-resistant variants and a large replicating virus population in macaques infected with a simian immunodeficiency virus containing human immunodeficiency virus reverse transcriptase

Ultrasensitive single-genome sequencing: accurate, targeted, next generation sequencing of HIV-1 RNA.

Well-mixed plasma and tissue viral populations in RT-SHIV-infected macaques implies a lack of viral replication in the tissues during antiretroviral therapy

Y chromosome and HIV DNA detection in vaginal swabs as biomarkers of semen and HIV exposure in women

YKL-40, a marker of simian immunodeficiency virus encephalitis, modulates the biological activity of basic fibroblast growth factor

Zidovudine (AZT) Monotherapy Selects for the A360V Mutation in the Connection Domain of HIV-1 Reverse Transcriptase ⬇️